Ann Coloproctol.
2015 Aug;31(4):121-122. 10.3393/ac.2015.31.4.121.
Anti-tumor Necrosis Factor Therapy for Crohn Disease: Friend or Foe to the Surgeon?
- Affiliations
-
- 1Department of Surgery, Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Seoul, Korea. hungdai.kim@samsung.com
- KMID: 2169714
- DOI: http://doi.org/10.3393/ac.2015.31.4.121
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls
- Could Early Anti-Tumor Necrosis Factor Therapy Change the Prognosis of Crohn's Disease?
- A Case of Multiple Tuberculosis Associated with Infliximab Therapy in Crohn's Disease
- Biological Therapy for Inflammatory Bowel Disease in Children
- Recent Trends of Infliximab Treatment for Crohn's Disease
